MENU
KMDA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Kamada (KMDA) Ownership - Who owns Kamada?
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
2 Holzman Street
Phone
+972 89406472
Employees
378
Web
https://www.kamada.com
Details
Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
401.71M
P/E Ratio
22.31
Total Cash
65.99M
Projected Growth
0.66
Total Debt
11.42M
Revenue
169.52M
Risk (Beta)
1.14
Dividend Yield
N/A
Total Cash/Share
1.15
Total Debt/Equity
18.61
Revenue/Share
2.86 USD as % of share price
Fundamentals
KMDA
Capitalization
402M
P/E Ratio
22.31
Risk (Beta)
1.14
Dividend Yield
N/A
Total Cash
66M
Total Cash/Share
1.15
Total Debt
11.4M
Total Debt/Equity
18.61
Projected Growth (PEG Ratio)
0.66
Revenue/Share (as % of the share price)
2.86%
Revenue
170M
ROE
N/A
Book Value
260M
P/B Ratio
1.58
Cash Flow
N/A
Earnings
0.33
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
15.1M
Current Ratio
4.00
Current Revenue Per Employee
119663.10
Dividends Per Share - Security
N/A
EBITDA
34.2M
Float
N/A
Float - Current
N/A
Gross Income Margin
42.30
Revenue To Assets
5.29
Shares Held By Institutions
53.6M
Shares Outstanding - Current
57.5M
Total Liabilities
108M
Total Volume MTD
N/A
Value
-1
Gain YTD
20.601
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. KMDA showed earnings on August 13, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
a company, which engages in pharmaceutical business
Industry PharmaceuticalsGeneric
Profile
Fundamentals
Details
Industry
Biotechnology
Address
2 Holzman Street
Phone
+972 89406472
Employees
378
Web
https://www.kamada.com